These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34426905)

  • 21. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites.
    Attal H; Cohen-Hillel E; Meshel T; Wang JM; Gong W; Ben-Baruch A
    Exp Cell Res; 2008 Jan; 314(2):352-65. PubMed ID: 17996233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.
    Wilson C; Maxwell PJ; Longley DB; Wilson RH; Johnston PG; Waugh DJ
    PLoS One; 2012; 7(5):e36545. PubMed ID: 22590561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells.
    Fisher RC; Bellamkonda K; Alex Molina L; Xiang S; Liska D; Sarvestani SK; Chakrabarti S; Berg A; Jorgensen ML; Hatala D; Chen S; Aiello A; Appelman HD; Scott EW; Huang EH
    Neoplasia; 2019 Mar; 21(3):269-281. PubMed ID: 30738331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium.
    Malgorzata Goczalik I; Raap M; Weick M; Milenkovic I; Heidmann J; Enzmann V; Wiedemann P; Reichenbach A; Francke M
    J Neuroimmunol; 2005 Apr; 161(1-2):49-60. PubMed ID: 15748943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
    Russo RC; Garcia CC; Teixeira MM; Amaral FA
    Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of interleukin 8/C‑X-C chemokine receptor 1,/2 signaling reduces malignant features in human pancreatic cancer cells.
    Fu S; Chen X; Lin HJ; Lin J
    Int J Oncol; 2018 Jul; 53(1):349-357. PubMed ID: 29749433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
    Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
    Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
    Joseph PRB; Sawant KV; Rajarathnam K
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.
    Singh S; Wu S; Varney M; Singh AP; Singh RK
    Microvasc Res; 2011 Nov; 82(3):318-25. PubMed ID: 21749879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
    Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
    Front Immunol; 2021; 12():667177. PubMed ID: 34025668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis.
    Vermeersch G; Proost P; Struyf S; Gouwy M; Devos T
    Haematologica; 2024 Jul; 109(7):2060-2072. PubMed ID: 38426279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL8 and its cognate receptors in melanoma progression and metastasis.
    Singh S; Singh AP; Sharma B; Owen LB; Singh RK
    Future Oncol; 2010 Jan; 6(1):111-6. PubMed ID: 20021212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell migration to the chemokine CXCL8: paxillin is activated and regulates adhesion and cell motility.
    Cohen-Hillel E; Mintz R; Meshel T; Garty BZ; Ben-Baruch A
    Cell Mol Life Sci; 2009 Mar; 66(5):884-99. PubMed ID: 19151925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
    Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
    J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porcine CXCR1/2 antagonist CXCL8
    Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
    Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.